MétaCan
Menu
Back to cohort
Record W2119463447 · doi:10.12927/hcpol.2005.17570

Public Drug Plan Coverage for Children Across Canada: A Portrait of Too Many Colours

2005· article· en· W2119463447 on OpenAlexafffundvenueabout
Wendy J. Ungar, Maciej Witkoś

Bibliographic record

VenueHealthcare policy · 2005
Typearticle
Languageen
FieldMedicine
TopicPharmaceutical studies and practices
Canadian institutionsHospital for Sick Children
FundersCanadian Institutes of Health ResearchHospital for Sick Children
KeywordsBiostatisticsPublic healthHealth carePortraitClinical epidemiologyLibrary scienceSociologyPolitical sciencePublic policyHealth policyEpidemiologySocial scienceMedicineHistoryLawNursingArt history

Abstract

fetched live from OpenAlex

Background: As debate continues regarding pharmacare in Canada, little discussion has addressed appropriate drug plan coverage for vulnerable populations, such as children.The primary objective of this study was to determine the extent of medication coverage for children in publicly administered programs in each province across Canada.Methods: Data were collected on provincial, territorial and federal government drug plans, and 2003 formulary updates were obtained.A simulation model was constructed to demonstrate costs to a low-income family with an asthmatic child in each province.Programs were compared descriptively.The extent of interprovincial variation in 2003 formulary approvals was summarized statistically.Results: There was 39% variation between provinces with respect to 2003 formulary approvals (chi-square p < 0.0001) and 48% variation for 2003 paediatric-labelled products (chi-square p < 0.0001).Across Canada, only 8% of 2003 formulary approvals were indicated primarily for paediatric conditions.In the simulation model, costs were less than or equal to 3% of household income in provinces with plans for low-income families, catastrophic costs (Ontario) or for the population.Families who failed to qualify for low income plans or who resided in New Brunswick or Newfoundland faced costs up to 7% of household income.Interpretation: With regard to pharmaceutical benefits for children, provincial drug programs vary considerably in terms of whom they cover, what drugs are covered and how much subscribers must pay out of pocket.Unlike seniors and social assistance recipients, the provinces do not agree on the importance of providing comprehensive coverage for all children.For many Canadian children, significant financial barriers exist to medication access. RésuméHistorique : Bien que le débat au sujet de l' assurance-médicaments au Canada se poursuive, on accorde peu d' attention à la question des régimes adéquats d' assurancemédicaments pour les populations vulnérables, dont les enfants.L' objectif premier de cette étude consistait à déterminer l' ampleur de la couverture accordée aux enfants par les programmes publics d' assurance-médicaments dans chaque province canadienne.Méthodes : On a recueilli des données relatives aux régimes d' assurance-médicaments des provinces, des territoires et du gouvernement fédéral et on a obtenu des formu- Public Drug Plan Coverage for Children Across Canada: A Portrait of Too Many Colours

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.066
Threshold uncertainty score0.481

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0020.005
Science and technology studies0.0030.002
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.098
GPT teacher head0.416
Teacher spread0.318 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations15
Published2005
Admission routes4
Has abstractyes

Explore more

Same venueHealthcare policySame topicPharmaceutical studies and practicesFrench-language works237,207